Literature DB >> 30846436

Brain MRI Findings in Pediatric-Onset Neuromyelitis Optica Spectrum Disorder: Challenges in Differentiation from Acute Disseminated Encephalomyelitis.

E Bulut1, J Karakaya2, S Salama3, M Levy4, T A G M Huisman5, I Izbudak6.   

Abstract

BACKGROUND AND
PURPOSE: Differentiating pediatric-onset neuromyelitis optica spectrum disorder from acute disseminated encephalomyelitis could be challenging, especially in cases presenting with only brain manifestations. Our purpose was to investigate brain MR imaging features that may help distinguish these 2 entities.
MATERIALS AND METHODS: We retrospectively examined initial brain MR imaging studies of 10 patients with pediatric-onset neuromyelitis optica spectrum disorder (female/male ratio, 7:3) and 10 patients with acute disseminated encephalomyelitis (female/male ratio, 2:8). The mean age of the patients was 10.3 ± 5.6 and 8.7 ± 5.3 years, respectively. Brain lesions were evaluated with respect to location, extent, expansion, T1 hypointensity, contrast enhancement/pattern, and diffusion characteristics. The χ2 test (Yates or Fisher exact χ2tests) was used to compare differences between groups.
RESULTS: Cerebral subcortical ± juxtacortical and pons ± middle cerebellar peduncle were the most frequent locations involved in both neuromyelitis optica spectrum disorder (n = 5 and 4, respectively) and acute disseminated encephalomyelitis (n = 9 and 7, respectively). Thalamic lesions were more frequent in acute disseminated encephalomyelitis (P = .020) and were detected only in 1 patient with neuromyelitis optica spectrum disorder. None of the patients with neuromyelitis optica spectrum disorder had hypothalamic, internal capsule, or cortical lesions. The internal capsule involvement was found to be significantly different between groups (P = .033). There was no significant difference in terms of extent, expansion, T1 hypointensity, contrast enhancement/pattern, and diffusion characteristics.
CONCLUSIONS: Although there is a considerable overlap in brain MR imaging findings, thalamic and internal capsule involvement could be used to differentiate pediatric-onset neuromyelitis optica spectrum disorder from acute disseminated encephalomyelitis.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 30846436      PMCID: PMC7048505          DOI: 10.3174/ajnr.A6003

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

1.  NMO in pediatric patients: brain involvement and clinical expression.

Authors:  Joaquín A Peña; María Elena Ravelo; Eduardo Mora-La Cruz; Cecilia Montiel-Nava
Journal:  Arq Neuropsiquiatr       Date:  2011-02       Impact factor: 1.420

2.  Brain abnormalities in neuromyelitis optica.

Authors:  Jee-Eun Kim; Sung-Min Kim; Suk-Won Ahn; Bung Chan Lim; Jong Hee Chae; Yoon-Ho Hong; Kyung-Seok Park; Jung-Joon Sung; Kwang-Woo Lee
Journal:  J Neurol Sci       Date:  2011-01-13       Impact factor: 3.181

3.  Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.

Authors:  Woojun Kim; Min Su Park; Sang Hyun Lee; Su-Hyun Kim; In Ja Jung; Toshiyuki Takahashi; Tatsuro Misu; Kazuo Fujihara; Ho Jin Kim
Journal:  Mult Scler       Date:  2010-08-04       Impact factor: 6.312

4.  Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.

Authors:  Woojun Kim; Su-Hyun Kim; Sang Hyun Lee; Xue Feng Li; Ho Jin Kim
Journal:  Mult Scler       Date:  2011-05-04       Impact factor: 6.312

Review 5.  Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders.

Authors:  Kevin Rostasy; Barbara Bajer-Kornek; Sunita Venkateswaran; Cheryl Hemingway; Marc Tardieu
Journal:  Neurology       Date:  2016-08-30       Impact factor: 9.910

6.  Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions.

Authors:  T Matsushita; N Isobe; T Matsuoka; T Ishizu; Y Kawano; T Yoshiura; Y Ohyagi; J Kira
Journal:  Mult Scler       Date:  2009-07-22       Impact factor: 6.312

7.  Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica.

Authors:  Shinji Saiki; Yuji Ueno; Toshio Moritani; Takeshi Sato; Takeshi Sekine; Sumihiro Kawajiri; Satoshi Adachi; Kazumasa Yokoyama; Yuji Tomizawa; Yumiko Motoi; Nobutaka Hattori
Journal:  J Neurol Sci       Date:  2009-06-03       Impact factor: 3.181

Review 8.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

9.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

10.  Neuromyelitis optica.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.972

View more
  4 in total

1.  Hypothalamic lesions in neuromyelitis optica spectrum disorders: exploring a scoring system based on magnetic resonance imaging.

Authors:  Wenjing Luo; Ling Fang; Zhanhang Wang; Zifeng Liu; Jinchi Liao; Zhanao Meng; Shishi Shen; Baozhu Liu; Rui Li; Allan G Kermode; Wei Qiu
Journal:  Jpn J Radiol       Date:  2021-03-10       Impact factor: 2.374

2.  Neuromyelitis optica spectrum disorder complicated with Sjögren's syndrome: first pediatric case responsive to mycophenolate mofetil treatment.

Authors:  Gao-Li Fang; Wei Fang; Yang Zheng; Yin-Xi Zhang
Journal:  Acta Neurol Belg       Date:  2020-11-02       Impact factor: 2.396

Review 3.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

4.  Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder.

Authors:  Ryan T Muir; Aditya Bharatha; Dalia Rotstein
Journal:  Front Neurol       Date:  2020-05-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.